Diagnosis and treatment of uncomplicated urinary tract infection (Q41649429)

6 October 2017

1 reference

title

Diagnosis and treatment of uncomplicated urinary tract infection (English)

1 reference

6 October 2017

Hooton TM

1

1 reference

6 October 2017

Stamm WE

series ordinal

2

1 reference

6 October 2017

publication date

1 September 1997

1 reference

Infectious Disease Clinics of North America

6 October 2017

published in

1 reference

6 October 2017

volume

11

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

551-581

1 reference

Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Use of quinolones in treatment of prostatitis and lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Uncomplicated E coli urinary tract infection in college women: a retrospective study of E coli sensitivities to commonly prescribed antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single Dose Oral Administration of Cefixime 400mg in the Treatment of Acute Uncomplicated Cystitis and Gonorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose enoxacin compared with 3-day treatment for urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Quinolones in the treatment of uncomplicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Sexual acquisition of urinary tract infection in a man

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary-tract infection in sexually active homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of pyelonephritis in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Development of antibacterial resistance: the Dutch experience

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A review of the problem of urinary infection management and the evaluation of a potential new antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Lactobacilli do not cause frequency and dysuria syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Management of acute dysuria. A decision-analysis model of alternative strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Review of clinical experience in the United States with cefpodoxime proxetil in adults with uncomplicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Prevention of subsequent urinary tract infections in women by the use of anti-adherence antimicrobial agents: a double-blind comparison of enoxacin with co-trimoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Are Excretory Urograms Necessary in Evaluating Women with Urinary Tract Infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Radiographic studies for women with recurrent urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Detection of bladder bacteriuria in patients with acute urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Recurring urinary tract infection: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Therapy of symptomatic pyelonephritis in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Significance of bacterial variants in urine of patients with chronic bacteriuria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Pharmacoeconomic Benefit of Antibiotic Step-Down Therapy: Converting Patents from Intravenous Ceftriaxone to Oral Cefpodoxime Proxettl

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose therapy for cystitis in women. A comparison of trimethoprim-sulfamethoxazole, amoxicillin, and cyclacillin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A prospective study of risk factors for symptomatic urinary tract infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Management of acute uncomplicated urinary tract infection in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Association of acute cystitis with the stage of the menstrual cycle in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose ceftriaxone versus multiple-dose trimethoprim-sulfamethoxazole in the treatment of acute urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Management of acute pyelonephritis in an emergency department observation unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections in women: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Renal ultrasonographic correlates of acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Comparison of 3-day versus 14-day treatment of lower urinary tract infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Localization of Urinary-Tract Infections by Detection of Antibody-Coated Bacteria in Urine Sediment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infection caused by Staphylococcus saprophyticus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of Acute Pyelonephritis in Women with Intramuscular Ceftriaxone: An Out-Patient Study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Acute Dysuria in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections in healthy university men.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections in females.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections in young adult women caused by Staphylococcus saprophyticus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Is the clean-catch midstream void procedure necessary for obtaining urine culture specimens from men?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Diagnosis of bacteriuria in men: specimen collection and culture interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Three-day therapy of lower urinary tract infections with nitrofurantoin macrocrystals: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of uncomplicated urinary tract infection in non-pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

The economic evaluation of antibiotic therapy: relevance to urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Broadening the concept of urinary tract infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Fastidious bacteria and the urethral syndrome: a 2-year clinical and bacteriological study of 51 women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Recurrent infection of the urinary tract: reinfection or recrudescence?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

1 reference

7 January 2021

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Identification of site of urinary-tract infections by antibody-coated bacteria assay

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Optimal characteristics of agents to treat uncomplicated urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Bacteriuria of pregnancy--a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Short-term treatment of uncomplicated lower urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Failure of excessive doses of ampicillin to prevent bacterial relapse in the treatment of acute pyelonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Laboratory in the diagnosis and management of urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose antibiotic treatment for uncomplicated urinary tract infections. Less for less?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Oral antibiotic therapy for acute pyelonephritis: a methodologic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

ED management of acute pyelonephritis in women: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of urinary tract infection. Clinical and economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single low-dose ofloxacin for the treatment of uncomplicated urinary tract infection in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Comparison of single-dose administration and three-day course of amoxicillin with those of clavulanic acid for treatment of uncomplicated urinary tract infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Quantitative urine culture in patients with urinary tract infection and bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Optimal duration of treatment for kidney infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Bacteriuria localization and response to single-dose therapy in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single dose treatment failure in women with acute cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Effect of 3- vs 10-day treatment of urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Pyelonephritis in adult women: inpatient versus outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Staphylococcus saprophyticus urinary tract infections: epidemiological data from Western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Acute cystitis: a prospective study of laboratory tests and duration of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Marital bacterial urinary infection in men

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Measurement of pyuria and its relation to bacteriuria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Diagnosis of coliform infection in acutely dysuric women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Management of urinary tract infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Urinary tract infections: from pathogenesis to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Natural history of recurrent urinary tract infections in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Effects of subinhibitory amounts of ampicillin, amoxycillin and mecillinam on the adhesion of escherichia coli bacteria to human urinary tract epithelial cells: A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

USA resistance patterns among UTI pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Relapse and Reinfection in Chronic Bacteriuria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Virulence characteristics of Escherichia coli in relation to host response in men with symptomatic urinary tract infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

An epidemiological survey of urinary tract infections among outpatients in Northern Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Effects of Subminimal Inhibitory Concentrations of Antibiotics on Adhesiveness of Escherichia coli in Vitro*

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

1 reference

7 January 2021

Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Treatment of pyelonephritis in an observation unit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Causes of frequency and dysuria in women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

The validity of urine examination for urinary tract infections in daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Sexual Acquisition of Urinary Tract Infection in a Man

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Asymptomatic bacteriuria. Which patients should be treated?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

Effect of subinhibitory antimicrobial concentrations (sub-MICs) on in-vitro bacterial adherence to uroepithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970373-1

7 January 2021

10.1016/S0891-5520(05)70373-1

Identifiers

DOI

1 reference

6 October 2017

1 reference